NewsEvents

Your Yourlocation: Home > Clinical application of short - acting preparations ipratropium bromide and long - acting preparation tiotropium bromide(136310-93-5)

It is recommended to use the long-acting β2 agonist and glucocorticoid inhalation agent to improve the lung function, increase the exercise tolerance and reduce the risk of moderate to severe COPD patients. Breathing difficulties, improve the quality of life. It is important to note that inhalation anticholinergics (including short-acting ipratropium bromide and long acting tiotropium bromide(136310-93-5)) may cause AUR to be used in the future.

Tiotropium bromide(136310-93-5) inhalation agent caused by urinary retention is rare, according to clinical observation, for most elderly male patients is safe, but once this adverse reaction may affect the outcome of the disease, to extend the length of stay. This case through the participation of clinical pharmacists, the use of their own professional advantages to identify and identify adverse drug reactions, participate in the re-development of treatment programs to avoid the increase in patient suffering and prolonged hospital stay. At the same time to provide pharmacy monitoring and medication guidance, so that the disease is more reasonable, for clinical pharmacists to participate in the clinical treatment group of clinical practice model provides a reference.

Address:211#Zhengfeng Building,Huanbaokejiyuan, Gaoxinkaifaqu, Jinan,250100,China TEL:086-531-82375818 Tiotropium Bromide
© Copyright(C)2014 JINAN DEXINJIA BIO & TECH CO., LTD All Rights Reserved